compound introduction
CRA-2059 is a highly specific and selective tryptase inhibitor, with a K i of 620 pM for recombinant human tryptase-β (rHTβ). Appearance:Solid In Vitro:Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 has the potential for inflammatory bowel disease research. MCE has not independently confirmed the accuracy of these methods Biological Activity:CRA-2059 is a highly specific and selective tryptase inhibitor, with a K i of 620 pM for recombinant human tryptase-β (rHTβ) .
